Premium
HbA 1c is not always reliable in estimating glycaemic control
Author(s) -
Mian Fahd Jan,
Jacob Koshy
Publication year - 2016
Publication title -
practical diabetes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.205
H-Index - 24
eISSN - 2047-2900
pISSN - 2047-2897
DOI - 10.1002/pdi.2063
Subject(s) - glycated haemoglobin , medicine , diabetes mellitus , comorbidity , diabetes control , glycated hemoglobin , intensive care medicine , type 2 diabetes , endocrinology
Glycated haemoglobin ( HbA 1c ) is considered as a cornerstone for assessing long‐term glycaemic control. Several studies have established a strong correlation between HbA 1c and diabetic comorbidities. However, in certain conditions it can lead to a false interpretation of diabetes control which may result in serious errors in patient management. It is essential clinicians are aware of the conditions that can affect glycated haemoglobin and use alternative methods of glycaemic control if there is a discrepancy between blood glucose readings and HbA 1c . We report a case of a falsely low HbA 1c which led to a wrong interpretation of glycaemic control resulting in a major comorbidity. Copyright © 2016 John Wiley & Sons.